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ABSTRACT 
Toxoplasma gondii is a parasite whose natural host is 
the caL Ocular toxoplasmosis can be categorized into 
two forms of infections: congenital, where an infant is 
infected in utero; and acquired, where an individual is 
typically infected by ingesting food contaminated with 
T. gondii oocytes. Although acquired infections are 
uncommon in the United States, toxoplasmosis should 
remain in the differential diagnosis of an infectious 
optic neuritis. 
The typical manifestation of toxoplasmosis is a 
retinochoroidltis, with a "headlight in the fog" appear-
ance, due to dense inflammation of the vitreous; 
consequently, the diagnosis is often made clinically. 
This case describes a healthy 36-year-old Hispanic male 
who had an atypical presentation of ocular toxo-
plasmosis, with minimal vitritis and papillomacular 
involvement; thus serology was necessary for a definitive 
diagnosis. Treatment led to a rapid improvement in 
vision and ultimately a good prognosis. 
INTRODUCTION 
Toxop/asma gondii is an obligate intracellular protozoan 
parasite. Nearly one third of humanity has been exposed 
to this organism; however, only l % to 3% will develop 
ocular manifestations. 1·l Despite the relatively low rate of 
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ocular involvement, T. gondii is one of the leading causes 
of posterior uveitis and is the leading cause of infectious 
retinochoroiditis worldwide. "1 The natural host of T. 
gondii is the feline family. Via fecal matter, cats release 
oocysts into the environment, which can remain viable for 
extended periods. Humans typically acquire infection by 
ingesting the oocysts found in contaminated soil, fruits, 
vegetables and undercooked meats or through congenital 
transmission in utero.4 The oocysts develop into tachyzoites, 
the primary infectious form of T. gondii, which cause 
acute tissue destruction and inflammation. Tachyzoites 
then transfonn into bradyzoites, which fonn protective 
cysts and may remain donnant until a precipitating event 
causes reactivation. i 
CASE STUDY 
A 36-year-old, healthy Hispanic male presented to a local 
optometrist with complaints of an acute onset of constant, 
blurred vision and "black specks" in the left eye that 
started earlier that morning. Prior lo this event, the patient 
had never experienced any vision abnormalities. His 
family ocular and medical history was unremarkable. 
He was not using any medications and had no known drug 
or environmental allergies. The patient was a police 
officer who had never smoked and consumed aJcohol only 
occasionally. He denied any sexually transmitted diseases. 
Unaided acuities were 6/4.5- (20/15-) in the right eye 
and 6/6- (20/20-) in the left; refraction yielded a low 
simple hyperopia in both eyes. Gross inspection and slit 
lamp examination were unremarkable, with no cells 
detected in the anterior chamber or in the vitreous in either 
eye. Ophthalmoscopy revealed no abnonnalities in the right 
eye but disclosed optic nerve edema in the left eye. 
Humphrey visual field, (HVF) 24-2 SITA Fast of the right 
eye was nonnal, but did show a generalized depression, with 
an enlarged blind spot in the left eye (Fig. l ). 
Following the examination, further discussion revealed 
a history of cold sores, with a recent labial infection. The 
patient also reported that he had experienced flu-like 
symptoms, with a low-grade fever, which had persisted for 
approximately two months. In addition, he noted that his 
daughter and his stepdaughter both had cats, but he denied 
changing the litter or having any close contact with either 
pet Lastly, he acknowledged that he enjoyed hunting and 
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Rg, 1 Initial Hum~ Wilial field 24·2 SITA-Fast, perfooned by the referring 
optometnst, sto.wd an OYerall depressioo and llfllaryed blind spot In the left 
eye The rti;lt WitJal field was~ and was not ltiooed. 
had recently handled deer meat The patient was referred to 
his primary care physician (PCP), with a recommendation 
to obtain an MRl of the brain and orbits. 
An MRI, with and without contras!, was perfonned 
as well as a CBC, CRP, ESR, thyroid panel, lipid profile 
and hepatic function testing. The MRI of the brain and 
orbits was unremarkable and clinical pathology revealed 
no abnormalities. Over the course of the following week, 
the patient's symptoms gradually worsened but there were 
no significant changes noted upon examination. 
A referral was then made to a neuro-ophthalmologist, 
who noted a 0.6 log unit afferent pupillary defect (APD), 
I+ vitrcal cells, and 4+ optic nerve edema in the left eye; 
examination of the right eye was unremarkable (Fig. 2). A 
visually evoked polential showed nonnal implicit times 
and amplitudes in both eyes. A multifocal electrorelino-
gram (mfERG) was nonnal in the right eye bul there was 
a reduced response in the inferior temporal field in the left 
eye (Fig. 3). Optical coherence tomography (OCT) of the 
right eye was nonnal but the left eye had significant 
subretinal fluid in the superior papillomacular bundle 
(Fig. 4). Intravenous fluorescein angiography (IVFA) 
showed no abnonnalities in the right eye, but disclosed 
diffuse leakage of the left optic disc, with no vascular or 
macular irregularities (Fig. 5). With evidence of an 
inflammatory process, a chest X-ray, PPD, ACE levels, 
RPR, FrA-ABS, HIV testing, Banonella antibodies, and 
Toxoplasma antibodies were requested. The patient was 
prescribed oral azithromycin while awaiting the results of 
the ancillary tests. 
Twelve days after the initial presentation, the patient 
requested to be seen emergently due to a sudden change 
in vision. His BCVAs remained 6/6 (20/20) in the right 
eye, but had declined 10 6/(IJ (20/200), with eccentric 
Ag. 2 Al the Initial neuro-ophlhalmology visit, there was massive edema 
of the lelt optic nerve, with perl-paplllary and pre-retinal hemorrhages, as wen as venous engorgement and a large area of serous fluid supero• 
temporally suggestive of neuroretlnlUs. The right eye was unremarkable. 
fixation, in the left The APD in the left eye had 
progressed to 0.9 log units and color perception by HRR 
plates was decreased in the left eye. Amsler grid showed 
a defect in the temporal half of the left eye and a HVF 24-2 
SITA Fast disclosed a generalized, relative, deep scotoma 
centered on the blind spot in the left eye (Fig. 6). The 
visual field of the right eye had low test reliability, 
but showed no significant defects. A repeat OCT 
demonstrated persistent subretinal fluid in the papillo-
macular bundle of the left eye, while the right eye 
remained unremarkable (Fig. 7). 
The patient was admitted to the hospital for observa-
tion. Soon thereafter, testing revealed T. gondii IgG and IgM 
antibodies, indicating a recently acquired toxoplasmosis 
infection. The patient was given a five-day course of 
pyrimetharnine, sulfadiazine, leucovorin calcium, methyl-
prednisolone succinate, valacyclovir, and pantoprazole. The 
patient was referred to the Center for Disease Control for 
evaluation of long-tenn antibiotic treatment 
The patient was last seen for a scheduled follow-up 
evaluation four months after the initial onset. Best-
corrected visual acuities were now 6/6 (20/20) in both 
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Fig. 3 MulUfocal electroreUnograrn of the right eye was normal but demonstrated reduced responses centrally and In the Interior-temporal quadrant of 
the left eye. 
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Fig, 4 Optical coherence tomography of the right eye was normal but the left eye had significant elevation of the optic nerve, with subretfnal Huld In the 
superior paplllomacular bundle. 
eyes. There was significant reduction in the optic nerve 
edema of the left eye, resolution of the pre-retinal and 
retinal hemorrhages, with mild residual retinal scarring 
(Figs. 8, 9). Humphrey visual fields demonstrated 
improvement in the left eye compared to prior testing 
(Fig. l 0). Initial findings of what may have progressed to 
a necrotic and non-resolving neuro-retinitis secondary to 
a T. gondii infection were almost entirely resolved. 
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DISCUSSION 
Although acquired T. gondii is rare in the United States, 
it is still a potential cause of infectious optic neuritis, as 
demonstrated by this case. Clinicians often diagnose ocular 
toxoplasmosis based on the signs of active retinochoroidal 
lesions, vitreous inflammation, and a "headlight in the fog" 
appearance, all of which are commonly found in immuno-
competent patients.1.s.6 However, this healthy male had 
J Fig. 5 Intravenous fluoresceln angiography showed no abnormalities In the right eye, but disclosed diffuse leakage ot the left optic disc, with no 
vascular or macular Irregularities. 
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Fig. 6 Humphrey visual field 24~2 SITA Fast of the felt eye showing a 
deep, arcuate defect surrounding the left blind spot and encroaching 
central vision 
minimal vitritis, with optic nerve involvement, which is 
an unusual presentation for toxoplasmosis.i Despite 
lack of significant vitreous inflammation, there is not 
necessarily reason to suspect that every patient is 
immunocompromised. It has been reported that deep 
retinal lesions (i.e., punctate outer retinal toxoplasmosis) 
are often associated with less vitreous inflammation, 
as in this case.' This atypical manifestation required the 
exclusion of other infectious entities that can produce an 
optic neuritis, such as toxocariasis, cat scratch disease, 
tuberculosis, sarcoidosis, Lyme disease, syphilis, herpes, 
or cytomegalovirus.0.1 Serology is supportive and the 
presence of lgM antibodies, detected by IFA and ELISA 
testing, indicates the presence of a recent infection. 
However, these tests are not diagnostic in every situation, 
as 20% to 70% of the general population can show 
positive titers.• It may be necessary to confinn difficult or 
atypical cases with paracentesis of the anterior chamber, 
using polymerase chain reaction, to detect T. gondii DNA 
in the aqueous.',. 
Indications for treatment vary considerably between 
practitioners! despite the fact that more than 94% of 
patients with ocular toxoplasmosis will have permanent 
visual defects, per automated perimetry.10 Many clinicians 
opt to monitor a peripheral lesion in an immunocompetent 
individual with good acuities, as the infections are typically 
self limiting•' However, reduced acuities, associated with 
lesions threatening major vessels, the optic nerve, and/or 
perifoveal areas, are indicators for treatment, as was seen 
in this case. 1.1 Treatment of vision threatening toxoplas-
mosis typically includes some combination of anti-
microbial and anti-parasitic agents, although their 
efficacy has not been proven in clinical trials. 11 Choices 
often involve a multidrug approach including pyrime-
thamine, with some combination of azithromycin, sulfadi-
azine, clindamycin, or sulfamethoxazole/trimethoprim. 
Patients treated with pyrimethamine should also receive 
folinic acid (leucovorin calcium) to minimize bone 
marrow suppression. 1•7•11•12 The use of oral prednisone, with 
concurrent antimicrobial treatment, may be beneficial in 
immunocompetent patients, especially when there is optic 
nerve and/or macular involvement. 1·1 However, one must 
consider that systemic therapy is expensive and can have 
significant side effects. A viable and potentially safer 
option for patients who cannot tolerate systemic therapy, 
is a combination of clindamycin and dexamethasone 
given as an intravitreal injection.1 u Longer-term treatment 
of ocular toxoplasmosis is aimed at reducing the severity 
and frequency of recurrences. Use of intermittent 
trimethoprim/sulfamethoxazole for several months has 
been shown to reduce the rate of recurrence., .... 
Management of choroidal neovascularization includes 
photodynamic therapy or anti-VEGF agents (intravitreal 
bevacizumab or ranibizumab).1•1'-11 
Toxoplasma gondii: An Atypical Presentation of Optic Neuritis - Holdeman et al 43 
, ...... , ... 
':+--• ... ca •• ~-· - • 
: ....-···:::;~ 
.L _,I .. ., ...... --
• 




n••a u: *a 
II .. • 
Fig. 7 Repeat opUcal coherence tomography documented persistent sub-retinal fluid In the paplllomacular bundle, with a serous retinal detachment of 
the rett eye, while the right eye remained within normal limits. 
fig. 8 Several weeks following treatment, OCT showed significant reduction of optic nerve edema, mild retinal scarring. and gradual dissipation of serous 
Nuld In the left eye. 
The ocular complications associated with toxo-
plasmosis include risk of recurrence, visual field defects, 
retinal detachment, sub-retinal neovascular membranes, 
cataracts, cystoid macular edema, papillitis, glaucoma, 
44 Clinical & Surgical Ophthalmology 32:2, 2014 
and chronic posterior uveitis.1' Since this patient had a 
newly acquired lesion, with optic nerve and macular 
involvement, frequent progress exams were indicated to 
properly manage potential complications. Fortunately, 
Fig. 9 Fundus photography of the left eye, four months after onset of 
symptoms, showed resoluUon of opUc nerve edema, fading of pre-reUna! 
and reUnal hemorrhages and mild residual reUnal scarring. 
early diagnosis and intervention led lo a good visual 
prognosis. 
CONCLUSION 
Although acquired ocular toxoplasmosis is uncommon in 
the United States, infection via contaminated food or 
water does occur.'"·'" Consequently, clinicians should con­
sider toxoplasmosis in cases of atypical optic neuritis and 
use appropriate tests to assist in the diagnosis and man­
agement. CJ 
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